I think that all is not completely lost.....This morning SONA investors began their day with disturbing news. The FDA was not intending to provide SONA as an emergency status COVID-19 test and the share-price spiraled to the down side by over $4.00 Canadian on massive selling volume. However, though I suppose a number of investors will disagree with my assessment, I don't think that SONA is a complete write-off. If I recall Saudi-Arabia was interested in the SONA's COVID-19 test as were others and HC has not yet finished evaluating the test data. After all, they must be interested in the test's potential if they have been asking additional questions of SONA about their test. It seems to me that they wouldn't be making further inquiries if SONA was no longer on their short-list for potential approvals. Further, it is important to understand that the big power players such as Phizer and others have submitted their own fast tests to the FDA and since they are US home-grown companies it stands to reason that their tests are going to get priority over international companies especially small companies like SONA. Remember, AMERICA FIRST! Also, the current US Administration has vowed that they will not be dependent on non-US drug or medical supplies providers ever again especially after they found out early on that a lot of the materials required for processing tests and used in the production of drugs all, or certainly a large number of them, come from China. So, please don't throw out the baby with the bath-water. Any way, that's my take on things. Wishing my fellow investors good fortune and good buys.